Exclusive

Publication

Byline

Location

AstraZeneca plans $15 B investment in China to expand medicines manufacturing and R&D

Singapore, Jan. 30 -- AstraZeneca has announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D. This investment will leverage the country's scientific excellenc... Read More


Vetter Pharma to build new manufacturing site in Germany

Singapore, Jan. 30 -- Vetter, one of the world's leading pharmaceutical service providers for the production of injectable drugs, has confirmed its plans to build a state-of-the-art production facilit... Read More


Singapore strengthens research and education for Traditional Chinese Medicine

Singapore, Jan. 29 -- Leading Traditional Chinese Medicine (TCM) healthcare group Gu Sheng Tang TCM, based in Hong Kong, and Nanyang Technological University, Singapore (NTU Singapore) have launched t... Read More


Baird Medical accelerates global commercial roadmap in partnership with Stonewood Key Capital in New Zealand

Singapore, Jan. 29 -- China-based Baird Medical Investment Holdings, a market leader in minimally invasive Microwave Ablation (MWA) technology, has announced a strategic partnership with Stonewood Key... Read More


Roche launches AI-enabled predictive CGM solution for diabetes management in Middle East

Singapore, Jan. 28 -- Roche Diagnostics Middle East presented a landmark launch event revealing Accu-Chek SmartGuide, a breakthrough Continuous Glucose Monitoring (CGM) innovation that sets a new stan... Read More


Singapore strengthens regulatory cooperation with Indonesia for medicine & health products

Singapore, Jan. 28 -- Singapore's Health Sciences Authority (HSA) and The Indonesian Food and Drug Authority have signed a Memorandum of Understanding (MoU), marking a significant milestone in cross-b... Read More


Korea's Hanmi Pharma secures export deal with Mexican partner Sanfer for GLP-1 obesity drug and more

Singapore, Jan. 28 -- Hanmi is accelerating its global market entry with efpeglenatide, Korea's first domestically developedGLP-1class obesity and metabolic disease treatment.Hanmi Pharmaceutical, the... Read More


Japan's Veritas In Silico partners with SpiroChem for discovery of next generation RNA drugs

Singapore, Jan. 28 -- Swiss firm SpiroChem AG and Japan-based Veritas In Silico Inc. have announced the signing of a Memorandum of Understanding (MoU) to collaborate on the discovery and experimental ... Read More


Boehringer Ingelheim, Simcere Pharma collaborate on €1,058 M IBD antibody deal

Singapore, Jan. 28 -- China-based Simcere Pharmaceutical Group and Germany-headquartered Boehringer Ingelheim have announced a license and collaboration agreement to develop SIM0709, a pre-clinical TL... Read More


Home Control teams up with NTU Singapore to explore AIoT home healthcare ecosystem

Singapore, Jan. 28 -- Singapore-based startup Home Control Internationalhas entered into a Strategic Memorandum of Understanding (MoU) with Nanyang Technological University, Singapore(NTU Singapore). ... Read More